3 completed, 2 not yet recruiting, 2 recruiting. 2 Not applicable, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Completed 1, Not yet recruiting 1 |
| Phase 1 | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
Follow Hypercholerolemia: new trials by email Literature Review of Hypercholerolemia trials Research Report on Hypercholerolemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Tracking Income Dynamics and Everyday Health Study Preventative health review invitation early in SNAP cycle, Financial counseling invitation early in the SNAP cycle, Aim 3 follow-up call early in the SNAP period - HIV, Hypertension | Not applicable | Not yet recruiting | University of Pennsylvania | 400 | 2027-03-01 | 2026-10-19 |
| Bioequivalence Study of AJU-C715 and C715R in Healthy Adult Volunteers Test Drug, Reference Drug - Hypercholerolemia, Dyslipidemia | Phase 1 | Completed | AJU Pharm Co., Ltd. | 61 | 2026-08-06 | 2026-09-09 |
| Faisalabad Initiative of Research and Management of NCDs Diabete Mellitus, Hypertension | Not yet recruiting | Getz Pharma | 3000 | 2026-08-01 | 2026-06-30 | |
| Cardiovascular-kidney-metabolic (CKM)-Guided Therapy for Patients After Acute Coronary Syndrome Rapid ESC-guideline based secondary prevention following myocardial infaction - Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI), Hypercholerolemia | Recruiting | Zuyderland Medisch Centrum | 1215 | 2026-03-16 | 2026-08-19 | |
| Effects of Statins and Hormone Replacement Therapy in Coagulation Profile of Menopausal Women With Dyslipidemia estroprogestins, Statin - Menopausal Complaints, Hypercholerolemia | Recruiting | University of Pisa | 70 | 2025-10-15 | 2026-08-03 | |
| Study of the Effects of Yerba Mate on Cardiometabolic Health Yerba mate tea, Control drink - Cardiovascular Risk, Hypercholerolemia | Not applicable | Completed | Instituto de Ciencia y Tecnología de Alimentos y Nutrición | 52 | 2012-01-10 | 2025-05-22 |
| A Study to Evaluate Ezetimibe in Korean Patients With Primary Hypercholesterolemia (0653-042) MK0653; ezetimibe / Duration of Treatment: 12 weeks, Comparator: simvastatin / Duration of Treatment: 12 weeks - Hypercholerolemia | Phase 3 | Completed | Organon and Co | 136 | 2002-12-01 | 2024-08-15 |
Hypertension (3) · Diabetes Mellitus (2) · Acute Coronary Syndrome (1) · Diabetes Mellitus, Type 2 (1) · Dyslipidemias (1) · Inflammation (1) · Obesity (1)
Metabolic Diseases (4) · Nutritional and Metabolic Diseases (4) · Cardiovascular Diseases (3) · Endocrine System Diseases (3) · Glucose Metabolism Disorders (3) · Vascular Diseases (3) · Pathological Conditions, Signs and Symptoms (2) · Body Weight (1) · Diabetes Mellitus (1) · Heart Diseases (1) · Lipid Metabolism Disorders (1) · Myocardial Ischemia (1) · Nutrition Disorders (1) · Overnutrition (1) · Overweight (1)
Drug Evaluation (1) · Duration of Therapy (1) · Ezetimibe (1) · Hormone Replacement Therapy (1) · Hydroxymethylglutaryl-CoA Reductase Inhibitors (1)
AJU Pharm Co., Ltd. (1) · Getz Pharma (1) · Instituto de Ciencia y Tecnología de Alimentos y Nutrición (1) · Organon and Co (1) · University of Pennsylvania (1) · University of Pisa (1) · Zuyderland Medisch Centrum (1)
Italy (1) · Netherlands (1) · South Korea (1) · Spain (1) · United States (1)
Laura Bravo, Professor (1) · Saman Rasoul, MD, PhD (1)
R01AG103431 (1)